3 Shares To Get Rich: GlaxoSmithKline plc, National Grid plc And Lloyds Banking Group PLC

Here are 3 companies that could improve your bottom line: GlaxoSmithKline plc (LON: GSK), National Grid plc (LON: NG) And Lloyds Banking Group PLC (LON: LLOY)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cash

Even though the FTSE 100 has pulled back in recent weeks and the future looks decidedly uncertain, in the long run investing in shares should pay off. Indeed, for investors willing to take risk, now could prove to be a great time to buy shares in top quality companies at slightly depressed prices.

Of course, no one company is likely to make you an millionaire overnight, but the following three stocks all trade at attractive valuations, have strong prospects and impressive yields. As such, they could help to improve your financial outlook.

GlaxoSmithKline

It’s been a tough time to be a GlaxoSmithKline (LSE: GSK) shareholder recently, with the company’s share price being hit due to allegations of corruption in China. However, looking ahead, GlaxoSmithKline has huge potential.

For starters, its pipeline is very strong and very well-diversified, with the potential to boost the company’s bottom line well into the future. In addition, shares in the company now trade on a price to earnings (P/E) ratio of just 12.3, which is significantly below the FTSE 100’s P/E of 13.3, while they currently yield a whopping 5.9%. As such, they could make for a profitable investment.

National Grid

One stock that is happy to be out of the headlines is National Grid (LSE: NG). While sector peers such as Centrica and SSE are continually bashed by the media, National Grid seems to make quiet progress while offering investors stunning income potential.

Indeed, the company currently yields an impressive 5.1% — but what matters more to investors is the company’s aim to increase dividend in-line with inflation over the medium term. This goal could mean sentiment improves for National Grid going forward, as a loose monetary policy is likely to mean higher rates of inflation in future years.

Lloyds

Lloyds (LSE: LLOY) had a fantastic year in 2013, with shares in the part government-owned bank rising by an incredible 61%. Of course, 2014 was bound to be a disappointment after such strong gains, but even so, many investors have been surprised at just how badly Lloyds has performed this year, with shares in the bank being down 7% year-to-date. However, this presents an opportunity to buy a stake in what looks set to be a very attractive income play.

Lloyds is forecast to pay a dividend of 3.2p per share next year, which at current prices equates to a yield of 4.4%. Furthermore, with profits and dividends set to increase over the next few years, Lloyds could see its share price bid up as investors seek out both strong growth potential and a generous yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline, Lloyds Banking Group, SSE, Centrica and National Grid. The Motley Fool has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »